710281-31-5

Upstream product

• 105-38-4 vinyl propionate 
• 108-05-4 vinyl acetate 

Downstream Products

• 710281-43-9 2-{1R,3S-3-[2-(3-Cyanophenyl)-5-methyloxazol-4-ylmethoxy]cyclohexyloxymethyl}-6-methylbenzoic Acid 
• 710281-30-4 methyl-2-{1R,3S-3-[2-(3-fluoro-phenyl)-5-methyl-oxazol-4-ylmethoxy]-cyclohexyloxymethyl}-6-methylbenzoate 
• 754239-16-2 methyl 2-((1R,3S)-3-allyloxycyclohexyloxymethyl)-6-methylbenzoate 

Relevant academic research and scientific papers

Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals

Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals The invention relates to diarylcycloalkyl derivatives and to their physiologically acceptable salts, racemates and physiologically functional derivatives. What is

Arylcycloalkyl derivatives having branched side chains, processes for their preparation and their use as pharmaceuticals

Arylcycloalkyl derivatives having branched side chains, processes for their preparation and their use as pharmaceuticals The invention relates to arylcycloalkyl derivatives having branched side chains and to their physiologically acceptable salts and phys

Process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives

Process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives A process is described for preparing chiral, nonracemic, cis-configured 1,3-disubstituted cyclohexanols of the formula (I) where the radicals are as defined, by

Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals

Diarylcycloalkyl derivatives and their physiologically acceptable salts and physiologically functional derivatives are disclosed. The compounds include those of formula I, in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparation. The compounds typically have lipid- and/or triglyceride-lowering properties and are suitable, for example, for the treatment of disorders of lipid metabolism, of type II diabetes, and of syndrome X.